PLA2G4A and neurodegenerative disease: Thus cPLA2 inhibition by AACOCF3 and PACOCF3 indicates a vital role for cPLA2 activation in neuronal death, and indicates a potential role for the use of cPLA2 inhibitors for neuroprotection in neurodegenerative diseases.